TCB-32 (Compound I-1) is a FGFR1 agonist with an EC50 of 0.88 µM. TCB-32 significantly increases cell proliferation through activating FGFR1 signaling pathway as bFGF and its downstream ERK 1/2 with excellent thermal stability. TCB-32 can replace bFGF in serum-free cell culture media. TCB-32 can be used for tissue repair and wound healing related diseases like psoriasis and eczema research[1][2].
Molecular Weight:
708.78
CAS Number:
[352513-86-1]
Formula:
C32H40N18O2
Target:
ERK,FGFR
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
